180 related articles for article (PubMed ID: 12600724)
1. Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion.
Khaldy H; Escames G; León J; Bikjdaouene L; Acuña-Castroviejo D
Neurobiol Aging; 2003; 24(3):491-500. PubMed ID: 12600724
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
Morgan WW; Nelson JF
Brain Res; 2001 Dec; 921(1-2):115-21. PubMed ID: 11720717
[TBL] [Abstract][Full Text] [Related]
3. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
4. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments.
Tang YP; Ma YL; Chao CC; Chen KY; Lee EH
J Neurosci Res; 1998 Sep; 53(5):593-604. PubMed ID: 9726430
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro.
Khaldy H; Escames G; León J; Vives F; Luna JD; Acuña-Castroviejo D
J Pineal Res; 2000 Sep; 29(2):100-7. PubMed ID: 10981823
[TBL] [Abstract][Full Text] [Related]
7. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
9. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
10. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum.
Thomas B; Mohanakumar KP
J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127
[TBL] [Abstract][Full Text] [Related]
11. Interactions among deprenyl, clorgyline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on catecholamines in mice.
Lee EH; Yang YL; Chia LG; Kuo JS
Neurosci Lett; 1994 Jan; 165(1-2):149-52. PubMed ID: 7912414
[TBL] [Abstract][Full Text] [Related]
12. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
Itzhak Y; Martin JL; Black MD; Ali SF
Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
[TBL] [Abstract][Full Text] [Related]
13. MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN).
Fredriksson A; Eriksson P; Archer T
J Neural Transm (Vienna); 1997; 104(6-7):579-92. PubMed ID: 9444559
[TBL] [Abstract][Full Text] [Related]
14. MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.
Ali SF; David SN; Newport GD; Cadet JL; Slikker W
Synapse; 1994 Sep; 18(1):27-34. PubMed ID: 7825121
[TBL] [Abstract][Full Text] [Related]
15. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J
Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165
[TBL] [Abstract][Full Text] [Related]
16. Rescue of dying neurons by (R)-deprenyl in the MPTP-mouse model of Parkinson's disease does not include restoration of neostriatal dopamine.
Steyn SJ; Castagnoli K; Castagnoli N
Ann N Y Acad Sci; 2001 Jun; 939():330-9. PubMed ID: 11462789
[TBL] [Abstract][Full Text] [Related]
17. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
[TBL] [Abstract][Full Text] [Related]
19. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
20. Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum.
Leret ML; San Millán JA; Fabre E; Gredilla R; Barja G
Toxicology; 2002 Jan; 170(3):165-71. PubMed ID: 11788154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
